Skip to content
HowShorted

REGENXBIO Inc. short interest in 2025

In 2025, REGENXBIO Inc.'s disclosed short interest ran from 12.28% of shares outstanding on 15 Jan 2025 to 9.82% on 31 Dec 2025, a change of -2.46 percentage points. The year's high was 12.93% on 31 Jan 2025 and its low 8.99% on 31 Oct 2025, averaging 11.01% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.38 days on 15 Sep 2025. Full history: REGENXBIO Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for REGENXBIO Inc. in 2025

2025 in figures

Start of year
12.28% (15 Jan 2025)
End of year
9.82% (31 Dec 2025)
Change
-2.46 pp
High
12.93% (31 Jan 2025)
Low
8.99% (31 Oct 2025)
Average
11.01%
Highest days to cover
11.38 (15 Sep 2025)
SEC filings marked
8

Every report in 2025

REGENXBIO Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202512.28%3.97
31 Jan 202512.93%7.96
14 Feb 202512.45%8.74
28 Feb 202512.68%8.38
14 Mar 202512.08%6.4910-K filed, results (8-K)
31 Mar 202510.42%4.71
15 Apr 202510.48%4.54
30 Apr 202510.32%5.76
15 May 202512.59%4.4510-Q filed, results (8-K)
30 May 202512.02%5.62
13 Jun 202511.01%4.37
30 Jun 202512.24%6.15
15 Jul 202512.34%11.26
31 Jul 202510.86%8.66
15 Aug 202510.83%7.6210-Q filed, results (8-K)
29 Aug 202510.17%8.11
15 Sep 202510.03%11.38
30 Sep 20259.87%9.62
15 Oct 20259.66%7.13
31 Oct 20258.99%8.64
14 Nov 20259.37%8.2110-Q filed, results (8-K)
28 Nov 202510.72%7.88
15 Dec 202510.09%7.73
31 Dec 20259.82%7.31

See also: REGENXBIO Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.